News | April 05, 2021
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Vivimed strategy is to increase its share of Branded products in CIS Markets.
Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
The company is expecting tremendous growth and a better quarterly performance
Subscribe To Our Newsletter & Stay Updated
